地屈孕酮对孕酮免疫测定分析干扰的评估
该研究系统评估了地屈孕酮(DYD)及其活性代谢物20α-二氢地屈孕酮(DHD)在七种常用孕酮测定中的潜在干扰。将含高、中、低浓度孕酮的人血浆池样本分别加入高、中、无浓度的DYD/DHD,由七个实验室用常规孕酮测定(六种免疫分析和一种液相色谱-串联质谱)盲法分析。结果显示中、高孕酮浓度下加标样本回收率在±10%窗口内,低浓度样本变异性较大但归因于方法间和方法内变异,未发现DYD/DHD有明显干扰。
要点
- 中、高孕酮浓度下DYD/DHD加标样本回收率在±10%内。
- 低孕酮浓度样本回收率变异性大,与低浓度方法变异有关。
- 七种常规孕酮测定未显示DYD/DHD相关干扰。
核心结论
- 本研究未发现地屈孕酮(DYD)及其代谢物DHD在常规孕酮测定中有相关干扰。
研究设计与样本
- 将匿名混合人血浆制成高、中、低三个孕酮浓度池,每个池样本加入高、中、无浓度DYD/DHD后分装盲法分析。
- 七个实验室分别用六种免疫分析和一种液相色谱-串联质谱测定孕酮,属于荷兰医学实验室质量评估基金会内分泌实验室诊断工作组的研究。
主要发现
- 中、高孕酮浓度下加标样本回收率在±10%窗口内。
- 低孕酮浓度样本回收率变异性较大,但归因于低浓度时方法间和方法内变异高。
关键数值与推荐
- 样本回收率定义为加DYD/DHD样本的孕酮结果除以未加DYD/DHD对应样本结果乘以100。
- 中、高孕酮浓度下回收率在±10%窗口内。
临床怎么用
- 常规孕酮免疫分析测定中不必因使用地屈孕酮而担心分析干扰。
局限性
- 低孕酮浓度样本的回收率变异性较大,与低浓度方法变异有关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Progesterone, a sex steroid, is measured in serum by immunoassay in a variety of clinical contexts. One potential limitation of steroid hormone immunoassays is interference caused by compounds with structural similarity to the target steroid of the assay. Dydrogesterone (DYD), an orally active stereoisomer of progesterone, is used for various indications in women's health. Herein, we report a systematic in vitro investigation of potential interference of DYD and its active metabolite 20α-dihydrodydrogesterone (DHD) in seven widely used, commercially available progesterone assays. METHODS: Routine human plasma samples were anonymized and pooled to create three graded concentration levels of progesterone (P4 high, P4 medium, P4 low). Each pooled P4 plasma sample (6-7 mL) was spiked at high, medium, and "none" concentration with DYD/DHD and was divided into 0.5 mL aliquots. The blinded aliquots were analyzed by seven different laboratories with their routine progesterone assay (six different immunoassays and one liquid chromatography-tandem mass spectrometry assay, respectively) within the Dutch working group on endocrine laboratory diagnostics of the Dutch Foundation for Quality Assessments in Medical Laboratories. RESULTS: The sample recovery rate (P4 result obtained for sample spiked with DYD/DHD, divided by the result obtained for the corresponding sample with no DYD/DHD × 100) was within a ±10% window for the medium and high P4 concentrations, but more variable for the low P4 samples. The latter is, however, attributable to high inter- and intra-method variability at low P4 concentrations. CONCLUSIONS: This study does not indicate any relevant interference of DYD/DHD within routinely used progesterone assays.
引用
- Eggersmann TK, Wolthuis A, van Amsterdam PH, et al. Lack of analytical interference of dydrogesterone in progesterone immunoassays. Clin Chem Lab Med. 2022. PMID: 35535412. doi:10.1515/cclm-2022-0174
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。